HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

HIV-TAT-survivin (T34A) protein

antineoplastic recombinant protein; base sequence in first source

Also Known As:

HIV-TAT-fusion protein; TAT-survivin (T34A)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
- Peptides: 82426
  - Intracellular Signaling Peptides and Proteins: 32
    - Apoptosis Regulatory Proteins: 2514
      - Inhibitor of Apoptosis Proteins: 717
        Survivin: 5441
        HIV-TAT-survivin (T34A) protein: 2

Experts

1.	Liu, Qinghai: 2 articles (05/2006 - 05/2006)
2.	Ma, Xingyuan: 2 articles (05/2006 - 05/2006)
3.	Ma, Yushu: 2 articles (05/2006 - 05/2006)
4.	Wang, Jinzhi: 2 articles (05/2006 - 05/2006)
5.	Wang, Tianwen: 2 articles (05/2006 - 05/2006)
6.	Wei, Dongzhi: 2 articles (05/2006 - 05/2006)
7.	Yang, Shengli: 2 articles (05/2006 - 05/2006)
8.	Zheng, Wenyun: 2 articles (05/2006 - 05/2006)

Related Diseases

1.

Neoplasms (Cancer)

05/29/2006 - "High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro."
05/01/2006 - "The findings suggested that recombinant protein TAT-survivin (T34A) has a bright future in cancer therapy targeting towards survivin, and the efficient procedure of expression and purification may be useful for the mass production of this therapeutically important protein."

Related Drugs and Biologics

1.	Recombinant Proteins
2.	Proteins (Proteins, Gene)
3.	Survivin

Related Therapies and Procedures

1.	Therapeutics